Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
1.110
-0.170 (-13.28%)
Nov 16, 2026, 4:00 PM EST - Market closed
CABA's stock price has decreased by -51.95% in the past year and price targets may not have had time to catch up.
Cabaletta Bio Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +620.72% | Nov 9, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $13 | Buy | Maintains | $13 | +1,071.17% | Nov 6, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $16 | Buy | Reiterates | $16 | +1,341.44% | Nov 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 2, 2026 |
Unknown Analyst Wells Fargo No rating | Wells Fargo | Hold Reiterates $3 | Hold | Reiterates | $3 | +170.27% | Sep 1, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $30 | Buy | Reiterates | $30 | +2,602.70% | Aug 14, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $16 | Buy | Reiterates | $16 | +1,341.44% | Aug 14, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 13, 2026 |